Pfizer vaccine safe after myocarditis, study confirms

No patient who'd been admitted with the condition previously had a repeat episode following mRNA vaccination, researchers say at ESC event

GPs can be reassured that patients who have had myocarditis in the past can safety receive the Pfizer-BioNTech coronavirus vaccine without causing the problem to recur, according to a new small study.

Rare cases of myocarditis following mRNA COVID-19 vaccination, primarily in young males after the second dose, have been reported in the medical literature.